Evidence map›Paper›PMID 27036341›Full record

ArticleThe Lancet. Infectious diseases2016

Non-randomised Ebola trials--lessons for optimal outbreak research.

Giuseppe Ippolito, Simone Lanini, Philippe Brouqui, Antonino Di Caro, Francesco Vairo, Francesco Maria Fusco, Sanjeev Krishna, Maria Rosaria Capobianchi, Henry Kyobe-Bosa, Vincenzo Puro and 8 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Giuseppe IppolitoLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy. Electronic address: giuseppe.ippolito@inmi.it.
Simone LaniniLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
Philippe BrouquiInstitut Hospitalier Universitaire Méditérranée Infection, Marseille, France.
Antonino Di CaroLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
Francesco VairoLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
Francesco Maria FuscoLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
Sanjeev KrishnaIfakara Health Institute, Dar-es-Salaam, Tanzania; Institute for Infection and Immunity, St George's, University of London, London, UK.
Maria Rosaria CapobianchiLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
Henry Kyobe-BosaMakerere University, Kampala, Uganda.
Vincenzo PuroLazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
Roman WölfelBundeswehr Institute of Microbiology, Munich, Germany.
Tatjana Avsic-ZupancInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
John P A IoannidisStanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA.
Gina PortellaEmergency NGO, Milan, Italy.
Peter KremsnerInstitut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany; Centre de Recherches Medicales de Lambarene, Lambarene, Gabon.
Osman DarChatham House Centre on Global Health Security, London, UK.
Matthew BatesUNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia.
Alimuddin ZumlaUNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia; Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre at UCL Hospitals NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease OutbreaksBiomedical ResearchHemorrhagic Fever, EbolaHumans

Identifiers

PMID27036341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.